Association Between Body Mass Index and Age of Presentation With Symptomatic Coronary Artery Disease
Author:
Affiliation:
1. Department of Cardiology; The Canberra Hospital; Canberra Australia
2. College of Medicine, Biology and Environment; Australian National University; Canberra Australia
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.22576/fullpdf
Reference23 articles.
1. Global Status Report on Noncommunicable Diseases;World Health Organization;Switzerland: World Health Organization,2014
2. Prevalence of childhood and adult obesity in the United States, 2011-2012;Ogden;JAMA.,2014
3. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study;Hubert;Circulation.,1983
4. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience;Wilson;Arch Intern Med.,2002
5. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants;Lu;Lancet,2014
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association of overweight and obesity with coronary risk factors and the presence of multivessel disease in patients with obstructive coronary artery disease – A nationwide registry study;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-09
2. Behavioral, Clinical, and Coronary Artery Calcium Screening for Prevention and Treatment of Subclinical Atherosclerosis: Implications for Health Education;American Journal of Health Education;2024-08-23
3. Dynamic changes in monocytic myeloid-Derived suppressor cells unveil insights into acute coronary syndrome pathogenesis and therapeutic potential;2024-07-16
4. Modifiable and Non-Modifiable Risk Factors for Premature Coronary Heart Disease (PCHD): Systematic Review and Meta-Analysis;Heart, Lung and Circulation;2024-03
5. Antihypertensive efficacy and safety of azilsartan medoxomil in patients with CАD, obesity and metabolic disorders. According to the CONSTANT study;Systemic Hypertension;2023-10-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3